Shree Ganesh Bio Stock Price Today (NSE: 539470)
Fundamental Score
Shree Ganesh Bio Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Shree Ganesh Bio share price today is ₹0.58, down 3.33% on NSE/BSE as of 17 June 2026. Shree Ganesh Bio (539470) is a Small-cap company in the Biotechnology sector with a market capitalisation of ₹25.51 (Cr). The 52-week high for 539470 share price is ₹0.89 and the 52-week low is ₹0.54. At a P/E ratio of 159.42x, 539470 is currently trading above its industry average P/E of 51.82x. The company has a Return on Equity (ROE) of 0.44% and a debt-to-equity ratio of 0.02.
Shree Ganesh Bio Share Price Chart — NSE/BSE Historical Performance
Shree Ganesh Bio share price chart: -3.17% return over the past month. 52-week high ₹0.89, 52-week low ₹0.54.
Shree Ganesh Bio — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹0.62 | ₹0.62 | ₹0.60 | ₹0.60 | 2.47L (Cr) | |
| ₹0.60 | ₹0.63 | ₹0.59 | ₹0.62 | 7.06L (Cr) | |
| ₹0.60 | ₹0.62 | ₹0.60 | ₹0.61 | 5.28L (Cr) | |
| ₹0.60 | ₹0.61 | ₹0.59 | ₹0.61 | 6.22L (Cr) | |
| ₹0.60 | ₹0.62 | ₹0.59 | ₹0.60 | 7.10L (Cr) | |
| ₹0.60 | ₹0.61 | ₹0.59 | ₹0.60 | 4.76L (Cr) | |
| ₹0.61 | ₹0.61 | ₹0.59 | ₹0.59 | 3.69L (Cr) | |
| ₹0.59 | ₹0.63 | ₹0.58 | ₹0.61 | 7.21L (Cr) | |
| ₹0.60 | ₹0.61 | ₹0.59 | ₹0.59 | 3.21L (Cr) | |
| ₹0.62 | ₹0.62 | ₹0.58 | ₹0.61 | 7.68L (Cr) |
Shree Ganesh Bio — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹0.62 | ₹0.62 | ₹0.60 | ₹0.60 | -3.23% | |
| ₹0.60 | ₹0.65 | ₹0.58 | ₹0.62 | +3.33% | |
| ₹0.54 | ₹0.71 | ₹0.54 | ₹0.61 | +12.96% | |
| ₹0.60 | ₹0.64 | ₹0.54 | ₹0.54 | -10.00% | |
| ₹0.65 | ₹0.70 | ₹0.60 | ₹0.63 | -3.08% | |
| ₹0.62 | ₹0.75 | ₹0.60 | ₹0.63 | +1.61% | |
| ₹0.61 | ₹0.65 | ₹0.58 | ₹0.62 | +1.64% | |
| ₹0.75 | ₹0.75 | ₹0.61 | ₹0.62 | -17.33% | |
| ₹0.77 | ₹0.78 | ₹0.73 | ₹0.74 | -3.90% | |
| ₹0.77 | ₹0.80 | ₹0.74 | ₹0.76 | -1.30% | |
| ₹0.80 | ₹0.81 | ₹0.75 | ₹0.77 | -3.75% | |
| ₹0.87 | ₹0.88 | ₹0.78 | ₹0.80 | -8.05% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Shree Ganesh Bio Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Shree Ganesh Bio Fundamental Analysis & Valuation Benchmarking
Educational evaluation of 539470 across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Consistent Growth Track Record (56.19% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
11 factors identified
Below-Average Return on Equity (0.44%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.62%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.59%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 159.42x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-96.88%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-61.11%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (3.15% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (3.13% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 1.42%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Shree Ganesh Bio vs Biotechnology Peers
Peer Comparison - Biotechnology
Compare Shree Ganesh Bio with 5 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
15.6/100 | ₹0.58₹1 | ₹25.51₹25.51 | 159.42Average 159.4 Average | 0.44%Poor 0.44% Poor | 0.62%Poor 0.62% Poor | 0.02Excellent 0.0 Excellent | 3.13%Average 3.13% Average | 56.19%Excellent 56.19% Excellent | 0.00% | |
Anthem Biosciences LimitedAnthem Bioscien... ANTHEM • 544449 | 63.7/100 | ₹757.20₹757 | ₹37009.24₹37009.24 | 79.93Average 79.9 Average | 20.83%Excellent 20.83% Excellent | 28.50%Excellent 28.50% Excellent | 0.04Excellent 0.0 Excellent | 37.27%Excellent 37.27% Excellent | 23.86%Excellent 23.86% Excellent | 0.00% |
Advanced Enzyme Technologies LtdAdvanced Enzyme... ADVENZYMES • 540025 | 63.6/100 | ₹371.75₹372 | ₹3493.23₹3493.23 | 23.70Average 23.7 Average | 9.54%Poor 9.54% Poor | 13.11%Average 13.11% Average | 0.02Excellent 0.0 Excellent | 0.26%Average 0.26% Average | 7.48%Good 7.48% Good | 1.66% |
Genesis IBRC India LtdGenesis IBRC In... GENESIS • 514336 | 25/100 | ₹116.90₹117 | ₹177.38₹177.38 | — — | 51.62%Excellent 51.62% Excellent | 51.62%Excellent 51.62% Excellent | 0.00Excellent 0.0 Excellent | 105.89%Excellent 105.89% Excellent | — — | 0.00% |
Vivo Bio Tech LtdVivo Bio Tech L... VIVOBIOT • 511509 | 16/100 | ₹27.08₹27 | ₹68.05₹68.05 | 16.64Average 16.6 Average | 5.68%Poor 5.68% Poor | 9.04%Poor 9.04% Poor | 0.58Good 0.6 Good | -3.27%Poor -3.27% Poor | -3.35%Poor -3.35% Poor | 0.00% |
Genomic Valley Biotech LtdGenomic Valley ... GVBL • 539206 | 24.6/100 | ₹26.54₹27 | ₹8.81₹8.81 | 88.14Average 88.1 Average | 9.68%Poor 9.68% Poor | 11.83%Average 11.83% Average | 0.00Excellent 0.0 Excellent | 4.42%Average 4.42% Average | -0.24%Poor -0.24% Poor | 0.00% |
Top Biotechnology Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
Shree Ganesh Bio Quarterly Performance
Latest quarterly metrics for 539470 — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-61.11%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-96.88%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
56.19%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
3.13%
Compounded annual net profit growth over 5 years
Shree Ganesh Bio Technical Indicators
SMA 50, SMA 200, RSI and volume signals for 539470 — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Shree Ganesh Bio Financial Statements
Annual income statement, balance sheet and cash flow for Shree Ganesh Bio (539470) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Shree Ganesh Bio
About 539470 (Shree Ganesh Bio)
Shree Ganesh Bio (539470) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Biotechnology sector with a current m...arket capitalisation of ₹25.51 (Cr). Shree Ganesh Bio has delivered a Return on Equity (ROE) of 0.44% and a ROCE of 0.62%. The debt-to-equity ratio stands at 0.02, reflecting the company's capital structure. Investors tracking 539470 share price can monitor key metrics including P/E ratio, promoter holding of 0.00%, and quarterly earnings growth.
Company Details
539470 Share Price: Frequently Asked Questions
What is the current share price of Shree Ganesh Bio?
Shree Ganesh Bio (539470) trades at ₹0.58 on BSE. Market cap ₹25.51 (Cr). Educational data only.
What is the P/E ratio of Shree Ganesh Bio?
Shree Ganesh Bio has a P/E of 159.42x vs industry average 51.82x.
What is the Bull Run score for Shree Ganesh Bio?
Shree Ganesh Bio has a Bull Run score of 15.6/100 based on 25+ financial parameters.
Does Shree Ganesh Bio pay dividends?
Shree Ganesh Bio has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Shree Ganesh Bio?
Shree Ganesh Bio has ROE of 0.44%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Shree Ganesh Bio?
Shree Ganesh Bio has debt-to-equity of 0.02.
Is Shree Ganesh Bio a good investment?
Bull Run gives Shree Ganesh Bio a score of 15.6/100. This is not investment advice — consult a SEBI-registered advisor.